Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Immunogenicity of UNAIR Inactivated COVID-19 Vaccine in Healthy Populations Aged 18 Years and Above (Phase I/II)

NCT05226429 is registered in ClinicalTrials.gov with Dr. Soetomo General Hospital as lead sponsor.

NCT NCT05226429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05226429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Immunogenicity of UNAIR Inactivated COVID-19 Vaccine in Healthy Populations Aged 18 Years and Above (Phase I/II)
Lead sponsor
Dr. Soetomo General Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
February 8, 2022
Completion date
July 6, 2023
Enrollment
495 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pandemic, vaccine reaction